Botulinum toxin-containing pharmaceutical composition for atrial fibrillation

botulinum toxin · Meshalkin Research Institute of Pathology of Circulation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Botulinum toxin-containing pharmaceutical composition for atrial fibrillation, covering 2016-12-05 to 2016-12-05. Get the full timeline:

Most recent: Clinical Trial Update: The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation [Phase 2]

See pricing